Bladder Cancer Case Control Study of Arsenic in Water

This study has been completed.
Sponsor:
Information provided by:
National Institute of Environmental Health Sciences (NIEHS)
ClinicalTrials.gov Identifier:
NCT00011518
First received: February 22, 2001
Last updated: March 22, 2006
Last verified: March 2006

February 22, 2001
March 22, 2006
October 1997
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00011518 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Bladder Cancer Case Control Study of Arsenic in Water
Not Provided

This study is examining the relationship between ingested arsenic and bladder cancer in two areas of California where a large percentage of the population was exposed to drinking water containing arsenic at low to moderate levels.

Water supplies in many parts of the world contain naturally occurring arsenic. Previous studies have shown that arsenic at high doses can cause cancer of the bladder. The risk at lower doses is unknown. This study is examining the relationship between ingested arsenic and bladder cancer in central Nevada and Kings County, California, two areas where a large percentage of the population was exposed to drinking water containing arsenic at low to moderate levels. Approximately 200 people with bladder cancer and 400 people without bladder cancer will be included. Subjects are interviewed by telephone about past residences, occupations, diet, drinking water consumption, and other lifestyle factors. Arsenic measurements in well water have been collected from the appropriate state agencies and are being matched with residences and drinking water consumption rates to estimate lifetime arsenic exposures for each subject. People with bladder cancer will then be compared to those without to see if people with cancer were more likely to have lived in areas with arsenic in their drinking water.

Observational
Observational Model: Case Control
Time Perspective: Longitudinal
Not Provided
Not Provided
Not Provided
Not Provided
Bladder Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
600
July 2001
Not Provided

Cases must meet the following criteria:

  • Diagnosed with primary bladder cancer from January 1, 1997 until December 31, 2000.
  • Live in the following counties at the time of diagnosis: Churchill, Lyon, Mineral, Storey, Douglas, Carson City, Nevada, and Kings County, California
  • Ages 20-85 at the time of diagnosis.

Controls will be matched to cases based on gender and five year age groups.

Both
20 Years to 85 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00011518
7459-CP-001
Not Provided
Not Provided
National Institute of Environmental Health Sciences (NIEHS)
Not Provided
Not Provided
National Institute of Environmental Health Sciences (NIEHS)
March 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP